NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis $0.59 +0.05 (+9.23%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.54▼$0.6350-Day Range$0.53▼$0.8052-Week Range$0.52▼$2.91Volume18,585 shsAverage Volume60,548 shsMarket Capitalization$1.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get NanoVibronix alerts: Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About NanoVibronix Stock (NASDAQ:NAOV)NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More NAOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Stock News HeadlinesAugust 21, 2024 | finance.yahoo.comNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersAugust 18, 2024 | finance.yahoo.comNanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023)September 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.May 22, 2024 | businesswire.comNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganMay 16, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMay 16, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024May 14, 2024 | finance.yahoo.comNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldMay 1, 2024 | businesswire.comNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract AwardSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.April 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMarch 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 7, 2024 | morningstar.comNanoVibronix Inc NAOVDecember 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganSee More Headlines Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2024Today9/07/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-83.49% Pretax Margin-82.75% Return on Equity-74.98% Return on Assets-43.38% Debt Debt-to-Equity RatioN/A Current Ratio2.11 Quick Ratio1.16 Sales & Book Value Annual Sales$3.37 million Price / Sales0.49 Cash FlowN/A Price / Cash FlowN/A Book Value$1.02 per share Price / Book0.58Miscellaneous Outstanding Shares2,784,000Free Float2,684,000Market Cap$1.65 million OptionableNot Optionable Beta1.53 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Brian M. Murphy (Age 67)CEO & Director Comp: $342.5kMr. Stephen R. Brown CPA (Age 68)Chief Financial Officer Comp: $276.5kDr. Harold Jacob M.D. (Age 70)Chief Medical Officer & Director Mr. Amir RippelVice President of MarketingMs. Lindsey HarrisonVice President of SalesKey CompetitorsPredictive OncologyNASDAQ:POAIHoldco Nuvo Group D.GNASDAQ:NUVOSonendoNYSE:SONXAethlon MedicalNASDAQ:AEMDIntelligent Bio SolutionsNASDAQ:INBSView All CompetitorsInstitutional OwnershipArmistice Capital LLCSold 114,005 shares on 8/15/2024Ownership: 4.917%View All Institutional Transactions NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed this year? NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV shares have decreased by 48.5% and is now trading at $0.5919. View the best growth stocks for 2024 here. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) posted its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.25) earnings per share for the quarter. The business had revenue of $0.82 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 74.98% and a negative net margin of 83.49%. When did NanoVibronix's stock split? Shares of NanoVibronix split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were distributed to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Who are NanoVibronix's major shareholders? NanoVibronix's top institutional investors include Armistice Capital LLC (4.92%). Insiders that own company stock include Christopher M Fashek and Aurora Cassirer. View institutional ownership trends. How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and BIO-key International (BKYI). This page (NASDAQ:NAOV) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.